Catalyst
Slingshot members are tracking this event:
GlaxoSmithKline (GSK) Expects to File Canadian Biologics License Application (BLA) for Shingrix Vaccine in the Prevention of Shingles in 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GSK |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 25, 2016
Occurred Source:
http://www.gsk.com/en-gb/media/press-releases/2016/gsk-announces-eu-regulatory-submission-of-candidate-vaccine-for-prevention-of-shingles-follows-regulatory-submissions-in-us-and-canada/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Biologics License Application, Vaccine, Shingles, Prevention, Herpes Zoster
